These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10659018)

  • 21. Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor.
    Nagane M; Narita Y; Mishima K; Levitzki A; Burgess AW; Cavenee WK; Huang HJ
    J Neurosurg; 2001 Sep; 95(3):472-9. PubMed ID: 11565870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
    FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
    Cai DW; Mukhopadhyay T; Roth JA
    Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
    Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
    J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
    Dorai T; Kobayashi H; Holland JF; Ohnuma T
    Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
    Kobayashi H; Dorai T; Holland JF; Ohnuma T
    Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
    Grzelinski M; Bader N; Czubayko F; Aigner A
    Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM; Nute EJ; Davis JG; Wu C; Lee A; Murali R; Zhang HT; Qian X; Kao CC; Greene MI
    Oncogene; 1998 Mar; 16(9):1197-207. PubMed ID: 9528862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme.
    Chen S; Song CS; Lavrovsky Y; Bi B; Vellanoweth R; Chatterjee B; Roy AK
    Mol Endocrinol; 1998 Oct; 12(10):1558-66. PubMed ID: 9773979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27.
    Park KH; Lee J; Yoo CG; Kim YW; Han SK; Shim YS; Kim SK; Wang KC; Cho BK; Lee CT
    J Neurosurg; 2004 Sep; 101(3):505-10. PubMed ID: 15352609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.
    Li QX; Robbins JM; Welch PJ; Wong-Staal F; Barber JR
    Nucleic Acids Res; 2000 Jul; 28(13):2605-12. PubMed ID: 10871412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme.
    Luo X; Gong X; Tang CK
    Int J Cancer; 2003 May; 104(6):716-21. PubMed ID: 12640678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro.
    Klebba C; Ottmann OG; Scherr M; Pape M; Engels JW; Grez M; Hoelzer D; Klein SA
    Gene Ther; 2000 Mar; 7(5):408-16. PubMed ID: 10694823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras.
    Scherr M; Maurer AB; Klein S; Ganser A; Engels JW; Grez M
    Gene Ther; 1998 Sep; 5(9):1227-34. PubMed ID: 9930324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.